Aqua Pharmaceuticals appoints Kimberley Forbes-McKean vice-president of R&D
This article was originally published in Scrip
Executive Summary
Aqua Pharmaceuticals has appointed Kimberley Forbes-McKean vice-president of R&D. Dr Forbes-McKean will be responsible for preclinical and clinical development and regulatory affairs. She was most recently executive vice-president and chief scientific officer at Cutanea Life Sciences.